Cytochrome P450 and gene activation - From pharmacology to cholesterol elimination and regression of atherosclerosis

European Journal of Clinical Pharmacology

Volumn 64, Issue 9, 2008, Pages 841-850

  Luoma, Pauli V ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ATP binding cassette A1; Coronary heart disease; Cytochrome P450; HDL cholesterol; Liver X receptor pregnane X receptor; Oxysterol

Indexed keywords

ABC TRANSPORTER A1; ANTICONVULSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CELL NUCLEUS RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL DERIVATIVE; COLESTYRAMINE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 3A4; CYTOCHROME P450 46A1; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OXYSTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOBARBITAL; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVATION; ENZYME INDUCTION; FATALITY; GENE ACTIVATION; GENE INDUCTION; HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW;

APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 50849145158     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0515-5     Document Type: Review

References (120)

1. AH Conney 1967 Pharmacological implications of microsomal enzyme induction Pharmacol Rev 19 317 366
2. H Remmer 1967 Die Induktion arzneimittelabbauender Enzyme im endoplasmatischen Retikulum der Leberzelle durch Pharmaka Dtsch Med Wochensch 92 2001 2008
3. T Omura R Sato DY Cooper O Rosenthal RW Estabrook 1965 Function of cytochrome P450 of microsomes Fed Proc 24 1181 1189
4. PV Luoma RO Pelkonen EA Sotaniemi 1979 Plasma high-density lipoprotein cholesterol and hepatic drug metabolizing enzyme activity in man Acta Physiol Scand Suppl 473 71
5. Luoma PV, Sotaniemi EA, Pelkonen RO, Ehnholm C (1980) Plasma high density lipoprotein and liver microsomal enzyme activity in man. In: Pilli-Sihvola AS, Laaksovirta TH (eds) The Medical Research Council 1977-1979. The Academy of Finland; Helsinki, p 71
6. T Gordon WP Castelli MC Hjortland WB Kannel TR Dawber 1977 High-density lipoprotein as a protective factor against coronary heart disease Am J Med 62 707 714
7. Miller NE, Miller GJ (Eds.) (1984) Clinical and metabolic aspects of high-density lipoproteins. Elsevier, Amsterdam New York Oxford
8. PV Luoma EA Sotaniemi RO Pelkonen 1983 Inverse relation of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal induction in man Res Commun Chem Pathol Pharmacol 42 173 176
9. PV Luoma EA Sotaniemi AJ Arranto 1983 Serum LDL cholesterol and LDL/HDL cholesterol ratio and liver microsomal induction evaluated by antipyrine kinetics Scan J Clin Lab Invest 43 671 675
10. PV Luoma 1997 Gene activation, apolipoprotein A-I/ high density lipoprotein, atherosclerosis prevention and longevity Pharmacol Toxicol 81 57 64
11. PV Luoma EA Sotaniemi RO Pelkonen VV Myllylä 1980 Plasma high density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment Scand J Clin Lab Invest 40 163 167
12. AYH Lu SB West 1980 Multiplicity of mammalian microsomal cytochromes P450 Pharmacol Rev 31 277 295
13. DW Nebert DW Russell 2002 Clinical importance of the cytochromes P450 Lancet 360 1155 1162
14. BA Janowski PJ Willy TR Devi JR Falck DJ Mangelsdorf 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXRα Nature 383 728 731
15. JM Lehmann SA Kliewer LB Moore TA Smith-Oliver BB Oliver JL Su SS Sundseth DA Winegard DE Blanchard TA Spencer TM Willson 1997 Activation of the nuclear receptor LXR by hydroxycholesterols defines a new hormone response pathway J Biol Chem 272 3137 3140
16. RO Bonow LA Smaha SC Smith GA Mensah C Lennfant 2002 The international burden of cardiovascular disease: Responding to the emerging global epidemic Circulation 106 1602 1605
17. PV Luoma MJ Savolainen EA Sotaniemi RO Pelkonen AJ Arranto Ehnholm 1983 Plasma high density lipoprotein and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction Acta Med Scand 214 103 109
18. YU Chao CB Pickett TT Yamin LS Guo A Alberts PA Kroon 1985 Phenobarbital induces rat liver apoliprotein A-I mRNA Mol Pharmacol 27 394 398
19. C Malmendier C Delcroic 1985 Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia Atherosclerosis 55 161 169
20. SP Tam 1991 Effects of gemfibrozil and ketoconazole on human apolipoprotein A-I and E levels in two hepatoma cell lines HepG2 and HepG3 Atherosclerosis 91 51 61
21. EM Rubin MR Krauss EA Spangler JG Verstuyft MS Clift 1991 Inhibition of early atherogenesis in transgenic mice by human apoprotein A-I Nature 353 265 267
22. H Glyling H Vanhanen TA Miettinen 1993 Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia J Lipid Res 34 59 67
23. J-Z Guan N Tamasava H Murakami J Matsui K Yamato T Suda 2003 Clofibrate,a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and hydroxycholesterol generation Tohoku J Exp Med 201 251 259
24. B Schneider R Gerdsen J Plat S Dullens I Björkhem U Dicsfalusy P Neuvonen T Biber K von Bergmann D Lütjohann 2007 Effects of high-dose itraconazole treatment on lipoproteins in men Int J Clin Pharmacol Ther 45 377 384
25. JJ Cali CL Hsieh U Francke DW Russell 1991 Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis J Biol Chem 266 7779 7783
26. CR Pullinger C Eng G Salen S Shefer AK Barra SK Erickson A Verhagen CR Rivera SJ Mulvihill MJ Malloy JP Kane 2002 Human cholesterol 7α-hydroxylase [CYP7A1] deficiency has a hypercholesterolemic phenotype J Clin Invest 110 109 117
27. I Björkhem U Diczfalusy D Lütjohann 1999 Removal of cholesterol from extrahepatic sources by oxidative mechanisms Curr Opin Lipidol 10 161 165
28. P Tontonoz DJ Mangelsdorf 2003 Liver X receptor signaling pathways in cardiovascular disease Mol Endocrinol 17 985 993
29. DS Ory 2004 Nuclear receptor signalling in the control of cholesterol homeostasis: have the orphans found a home Circ Res 95 660 670
30. I Björkhem U Diczfalusy 2002 Hydroxycholesterols - friends, foes or just fellow passangers Arterioscler Thromb Vasc Biol 22 734 742
31. JYL Chiang 2003 Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors Am J Physiol Gastrointest Liver Physiol 284 349 356
32. G Eggertsen M Olin U Andersson H Ishida S Kubota U Hellman K-I Okuda I Björkhem 1996 Molecular cloning and expression of rabbit sterol 12α-hydroxylase J Biol Chem 271 32269 32275
33. X Fu JG Menke Y Chen G Zhou KL MacNaul SD Wright CP Sparrow EG Lund 2001 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol loaded cells J Biol Chem 276 38378 38387
34. M Andersson U Norlin U Björkhem 2000 Oxysterol 7α-hydroxylase activity by cholesterol 7α-hydroxylase (CYP7A) J Biol Chem 275 34046 34053
35. I Björkhem 2006 Crossing the barrier: hydroxycholesterols as cholesterol transporters and metabolic modulators in the brain J Intern Med 260 493 508
36. U Panzenboeck Z Balazs A Sovic A Hrzenjak S Levak-Frank A Wintersperger E Malle W Sattler 2002 ABCA1 and scavenger receptor class B, type I, are modulators of reverse cholesterol transport at an in vitro blood-brain barrier constituted porcine brain capillary endothelial cells J Biol Chem 277 42781 42789
37. GF Gibbons 2002 The role of cytochrome P450 in the regulation of cholesterol biosynthesis Lipids 37 1163 1170
38. SE Saucier AA Kandutsch AK Gayen DK Swahn TA Spencer 1989 Hydroxycholesterol regulators of 3-hydroxy-3-methylglutaryl-CoA reductase in liver. Effect of dietary cholesterol J Biol Chem 264 6863 6869
39. Yan D, Olkkonen VM (2007) The OSBP-related proteins (ORP)-lipid sensors or transporters? Fut Lipidol 2:85-94
40. Y Liang X-C Jiang R Liu G Liang TP Beyer H Gao TP Ryan SD Li PI Eacho G Cao 2004 Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists Mol Endocrinol 18 2000 2010
41. JJ Eloranta GA Kullak-Ublick 2005 Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism Arch Biochem Biophys 433 397 412
42. JM Lehmann DD McKee MA Watson TM Willson JT Moore SA Kliewer 1998 Human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J Clin Invest 102 1016 1023
43. W El-Sankary GG Gibson A Aurton N Plant 2001 Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers Drug Me Dispos 29 1499 1504
44. M Sinz S Kim Z Zhu T Chen M Anthony K Dickinson AD Rodrigues 2006 Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions Curr Drug Metab 7 375 388
45. K Bachmann H Patel Z Batayneh J Slama D White J Posey 2004 PXR and the regulation of apoA1 and HDL-cholesterol in rodents Pharmacol Res 50 237 246
46. J Sonoda LW Chong M Downes GD Barish S Coulter C Liddle CH Lee RM Evans 2005 Pregnane receptor prevents hepatorenal toxicity from cholesterol metabolites Proc Natl Acad Sci 102 2198 2203
47. EG Schuetz JD Schuetz SC Strom MT Thompson RA Fisher DT Molowa D Li PS Guzelian 1993 Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes Hepatology 18 1254 1262
48. T Kocarek MS Dahn H Cai SC Strom NA Mercer-Haines 2002 Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes Drug Metab Disp 30 1400 1405
49. C Bertrand-Thiebault C Masson G Siest AM Batt S Visvikis-Siest 2007 Effect of MHGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line J Cardiovasc Pharmacol 49 306 315
50. T Li JYL Chen W Chiang 2007 PXR induces CYP27A1 and regulates metabolism in the intestine J Lipid Res 48 373 384
51. A Chawla W Boisvert C-H Lee BA Laffitte Y Barak SB Joseph D Liao L Nagy PA Edwards LK Curtiss RM Evans P Tontonoz 2001 A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol Cell 7 161 171
52. G Chinetti S Lestavel V Bocher AT Remaley B Neve IP Torra E Teissier A Minnich M Jaye N Duverger HB Brewer JC Fruchart V Clavey B Staels 2001 PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 53 58
53. P Linsel-Nitschke AR Tall 2005 HDL as a target in the treatment of atherosclerotic cardiovascular disease Nat Rev 4 193 205
54. HB Brewer Jr AT Remaley EB Neufeld F Basso C Jouce 2004 Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease Arterioscler Thromb Vasc Biol 24 1755 1760
55. LR Brunham KJ Kruit J Iqbal C Fievet JM Timmins T Pape 2006 Intestinal ABCA1 directly contributes to HDL biogenesis in vivo J Clin Invest 116 1052 1062
56. JJ Repa SD Turley JA Lobaccaro J Medina L Li K Lustig B Shan RA Heyman JM Dietschy DJ Mangelsdorf 2006 Regulation of absorption of ABCA1-mediated efflux of cholesterol by RXR heterodimers Science 289 1524 1529
57. JF Oram 2002 Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1 Trends Mol Med 8 168 173
58. J Klucken C Büchler E Orsó WE Kaminski M Porsch- Özcürümez G Liebisch M Kapinnsky W Diederich W Drobnik M Dean R Alllikmets G Schmitz 2000 ABCG1 [ABC8], the human homolog of the drosophila white gene, is regulator of macrophage cholesterol and phospholipid transport Proc Natl Acad Sci USA 97 817 822
59. L Yu J Li-Hawkins RE Hammer KE Berge JD Horton JC Cohen HH Hobbs 2002 Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol J Clin Invest 110 671 680
60. KE Berge H Tian GA Graf L Yu NV Grishin J Schultz P Kwiterovicch B Shan R Barnes HH Hobbs 2000 Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 1771 1553
61. G Martin H Duez C Blanquart V Berezowski P Poulain JC Fruchart J Najib-Fruchart C Glineur B Staels 2001 Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I J Clin Invest 107 1423 1432
62. P Fan B Zhang S Kuroki K Saku 2004 Pitavastatin, a potent hydroxymethylglutaryl Coenzyme A reductase inhibitor, increases 7α-hydroxylase gene expression in HepG2 cells Circ J 68 1061 1066
63. CA Argmann JY Edwards CG Sawyez CH O'Neil RA Hegele JG Pickering MW Huff 2005 Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl- CoA reductase inhibition J Biol Chem 280 22212 22221
64. T Maejima H Yamazaki T Aoki F Tamaki T Sato M Kitahara Y Saito 2004 Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell Biochem Biophys Res Commun 324 835 839
65. H Ando S Tsuruoka H Yamamoto T Takamura S Kaneko A Fujimura 2004 Effect of pravastatin on ATP-binding cassette transporter A1 J Pharmacol Exper Ther 311 420 425
66. A Gatica MC Aguilera D Contador G Loyola CO Pinto L Amigo JE Tichauer S Zanlungo M Bronfman 2007 P450 CYP2C epoxynase and CYP4A ω-hydroxylase mediate ciprofibrateinduced PPARα-dependent peroxisomal proliferation J Lipid Res 48 924 934
67. T Prueksaritanont KM Richards Y Qui K Strong-Basalyga A Miller C Li R Eisenhandler EJ Carlini 2005 Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes Pharmaceut Res 22 71 78
68. J Shepherd CJ Packard S Bicker TD Lawrie HG Morgan 1980 Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism New Engl J Med 302 1219 1222
69. J Shepherd 1979 The effect of cholestyramine on high density lipoprotein metabolism Atherosclerosis 33 433 44
70. JR Guyton 2007 Niacin in cardiovascular prevention: mechanisms, efficacy and safety Curr Opin Lipidol 18 415 420
71. K Bodin L Bretillon Y Aden L Bertilsson U Broome C Einarsson U Diczfalusy 2001 Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans J Biol Chem 276 38685 38689
72. JM Lehmann LB Moore TA Smith-Oliver WO Wilkison TM Wilson SA Kliewer 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor PPARγ J Biol Chem 270 12953 12956
73. A Szanto S Benko I Szatmari LB Balint I Furtos R Rühl S Molnar L Csiba R Garuti S Calandra H Laersson U Diczfalusy L Nagy 2004 Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signalling in macrophages Mol Cell Biol 24 8154 8166
74. CM Quinn W Jessup J Wong L Kritharides AJ Brown 2005 Expression and regulation of sterol 27-hydroxylase [CYP27A1] in human macrophages: a role for RXR and PPARγ ligands Biochem J 385 823 830
75. CD Myers ML Kashyap 2005 Pharmacological augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies Curr Opin Cardiol 20 307 312
76. CS Lieber 1984 To drink (moderately) or not to drink? New Engl J Med 310 846 848
77. CL Malmendier C Delcroix 1985 Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers Clin Chim Acta 152 281 288
78. EA Luoma PV Sotaniemi RO Pelkonen C Ehnholm 1982 High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers Res Commun Chem Pathol Pharmacol 37 91 96
79. R LaPorte L Valvo-Gerard L Kuller R Wanju M Bates J Cresanta K Williams D Palkin 1981 The relationship between alcohol consumption, liver enzymes and high-density lipoprotein cholesterol Circulation 64 Suppl 3 67 72
80. JW Beulens A Sierksma A van Tol N Fournier T van Gent J-L Paul HFJ Hendricks 2004 Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1 J Lipid Res 45 1716 1723
81. P Costet F Lalanne M Gerbod-Gionnone JR Molina X Fu EG Lund LJ Gudas AR Tall 2003 Retinoid acid receptor-mediated induction of ABCA1 in macrophages Mol Cell Biol 23 7756 7766
82. S Suzuki T Nishimaki-Mogami N Tamehiro K Inoue R Arakawa S Abe-Dohmae AR Tanaka K Ueda S Yokoyama 2004 Verapamil increase apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via liver X receptor-independent mechanism Arterioscler Thromb Vasc Biol 24 519 525
83. K Nakaya M Ayaori T Hisada S Sawada N Tanaka N Iwamoto M Ogura M Yakushji H Nakamura F Ohsuzu 2007 Telmisartan enhances cholesterol efflux from THP-macrophages by activating PPARγ J Atheroscler Thromb 14 133 141
84. S Zadelaar R Kleemann L Verschuren J de Vries-Van der Weij J van der Hoorn HM Princen T Kooistra 2007 Mouse models for atherosclerosis and pharmacological modifiers Arterioscler Thromb Vasc Biol 27 1706 1721
85. M Böhm 2007 Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now? Am J Cardiol 100 Suppl 38J 44J
86. 2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages J Leukoc Biol 6 727 734
87. R Ylitalo 2002 Biophosphonates and atherosclerosis Gen Pharmacol 35 287 296
88. D Strobach RL Lorenz 2003 The biophosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid cells by enhanced ABCA1 transcription Biochem Biophys Res Commun 307 23 30
89. SE Nissen SJ Nicholls I Sipahi P Libby JS Raichlen CM Ballantyne E Davignon JC Erbel JC Fruchart JC Tardif P Schoenhagen T Crowe V Cain K Wolski M Goormastic EM Tuzcu for the ASTEROID investigators 2007 Effect of very high-intensity statin therapy on regression of coronay atherosclerosis. The Asteroid Trial JAMA 295 1556 1565
90. S Okazaki T Yokoyama K Miyauchi K Shimada T Kurata H Sato H Daida 2004 Early statin treatment in patients with acute coronary syndrome. Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronay event: the ESTABLISH study Circulation 110 1061 1068
91. L Okkels Jensen P Thayssen KE Pedersen S Stender T Haghfelt 2004 Regression of coronary atherosclerosis by simvastatin. A serial intravascular ultrasound study Circulation 110 265 270
92. BG Brown K Hinckley Stukovsky XQ Zhao 2006 Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: meta-analysis of 23 randomized trial Curr Opin Lipidol 17 631 636
93. CG Ericsson U de Faire L Grip B Svane A Hamsten J Nilsson 1996 Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients Lancet 347 849 853
94. M Thoenes A Oguchi S Nagamia CS Vaccari R Hammoud GE Umpierrez BV Khan 2007 The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome Int J Clin Pract 61 1942 1948
95. SJ Nicholls E Murat I Sipahi AW Grasso P Schoenhagen T Hu K Wolski T Crowe MY Desai SI Hazen SR Kapadia SE Nissen 2007 Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis JAMA 297 499 508
96. S Kiehl J Willeit G Rungger G Egger F Oberhollenzer E Bonora fort the Bruneck Study Group 1998 Alcohol consumption and atherosclerosis: what is the relation. Prospective results from the Bruneck study Stroke 29 900 907
97. R Femia A Natali A L'Abbate E Ferrannini 2006 Coronay atherosclerosis and alcohol consumption. Angiographic and mortality data Arterioscler Thromb Vasc Biol 26 1607 1612
98. MR Langenfeld T Forst C Hohberg P Kann G Lübben T Konrad SD Füllert C Sachara A Pfützner 2005 Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus. Results from a controlled randomized study Circulation 111 2525 2531
99. H Koshiyama Y Nakamura S Tanaka J Minamikawa 2000 Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes J Clin Endocrinol Metab 85 2793 2796
100. BMY Cheung IJ Lauder C-P Lau C Kumana 2004 Meta-analysis of large randomised controlled trials to evaluate the impact of statins on cardiovascular outcomes Brit J Clin Pharmacol 57 640 651
101. Cholesterol Treatment Trialists' [CTT] Collaborators 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Lancet 366 1267 1278
102. VG Athyros DP Mikhailidis AA Papageorgiou AN Symeonidis BR Mercouris AN Pehlivanidis VI Bouloukos M Elisaf for the GREACE Study Collaborative Group 2004 Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease evaluation (GREACE) study Curr Med Res Opin 20 627 637
103. L Tenkanen M Mänttäri PT Kovanen H Virkkunen V Manninen 2006 Gemfibrozil in the treatment of dyslipidemia. An 18-year follow-up of the Helsinki Heart Study Arch Intern Med 166 743 748
104. A Muuronen M Kaste E Nikkilä E-M Tolppanen 1985 Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study Brit Med J 291 1481 1483
105. K Poikolainen 1995 Alcohol and mortality: a review J Clin Epidemiol 48 455 465
106. JA Dormandy B Charbonnel DAJ Eckland E Erdmann M Massi-Benedetti IK Moules on behalf of the PROactive investigators 2005 Secondary prevention of macrovascular events in patients with type 2 diabetes in the Proactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 1279 1289
107. SE Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2457 2471
108. P Astrup K Kjeldsen J Wanstrup 1970 Effects of carbon monoxide exposure on the arterial walls Ann NY Acad Sci 174 294 300
109. B Hedblad M Ögren G Engström P Wollmer L Janzon 2005 Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure Atherosclerosis 179 1771 1783
110. C Ehnholm K Aho JK Huttunen E Kostiainen K Mattila J Pikkarainen K Cantell 1982 Effect of interferon on plasma lipoproteins and the activity of postheparin plasma lipases Arteriosclerosis 2 68 74
111. AB Reiss CA Patel MM Rahman ESL Chan K Hasneen MM Montesinos JD Trachman BN Cronstein 2004 Interferon-γ impedes reverse cholesterol transport and promotes foam cell transformation in TPH-1 human monocytes/macrophages Med Sci Monit 10 BR420 BR425
112. VG Panousis SH Zuckerman 2000 Interferon-γ induces downregulation of Tangier disease gene [ATP-binding cassette transporter 1] in macrophage derived foam cells Arterioscler Thromb Vasc Biol 20 1565 1571
113. SE Nissen JC Tardif SJ Nicholls JH Revkin CL Shear 2007 Effect of torcetrapib on the progression of coronary atherosclerosis New Engl J Med 356 1304 1316
114. SU Naik X Wang JS Da Silva M Jaye CH Macphee MR Reilly JT Billheimer GH Rothblat DJ Rader 2006 Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo Circulation 113 90 97
115. N Levin ED Bischoff CL Daige D Thomas CT Vu RA Heyman RK Tangirala IG Schulman 2005 Macrophage liver X receptor is required for anti-atherogenic activity of LXR agonists Arterioscler Thromb Vasc Biol 25 135 142
116. PV Luoma EA Sotaniemi RO Pelkonen HI Pirttiaho 1985 Serum low density and high density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes Eur J Clin Pharmacol 28 615 618
117. L Bretillon D Stahle T Widhe L Bindl G Eggertsen U Diczfaluzy I Björkhem 2000 Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J Lipid Res 41 840 845
118. CL Wellington EKY Walker A Suarez A Kwok N Bissada R Singaraja YZ Yang LH Zhang E James JE Wilson O Francone BM McManus MR Hayden 2002 ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation Lab Invest 82 273 283
119. M Lehrke C Lebherz SC Millington HP Guan J Millar DJ Rader JM Wilson MA Lazar 2005 Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα Cell Metab 1 297 308
120. SA Kliewer 2005 Cholesterol detoxification by nuclear pregnane X receptor Proc Natl Acad Sci USA 102 2675 2676